SUNPHARMA.NS vs. NTPC.NS
Compare and contrast key facts about Sun Pharmaceutical Industries Limited (SUNPHARMA.NS) and NTPC Limited (NTPC.NS).
Performance
SUNPHARMA.NS vs. NTPC.NS - Performance Comparison
Loading graphics...
SUNPHARMA.NS vs. NTPC.NS - Yearly Performance Comparison
| 2026 (YTD) | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | |
|---|---|---|---|---|---|---|---|---|---|---|
SUNPHARMA.NS Sun Pharmaceutical Industries Limited | -0.88% | -7.98% | 51.11% | 27.16% | 19.74% | 44.40% | 38.20% | 1.13% | -24.40% | -8.73% |
NTPC.NS NTPC Limited | 9.96% | 1.49% | 9.71% | 96.38% | 40.35% | -209.73% | -156.77% | 0.42% | -13.14% | 10.51% |
Returns By Period
In the year-to-date period, SUNPHARMA.NS achieves a -0.88% return, which is significantly lower than NTPC.NS's 9.96% return. Over the past 10 years, SUNPHARMA.NS has underperformed NTPC.NS with an annualized return of 8.50%, while NTPC.NS has yielded a comparatively higher 9.92% annualized return.
SUNPHARMA.NS
- 1D
- -2.02%
- 1M
- -3.36%
- YTD
- -0.88%
- 6M
- 4.18%
- 1Y
- -0.20%
- 3Y*
- 21.17%
- 5Y*
- 23.85%
- 10Y*
- 8.50%
NTPC.NS
- 1D
- -1.37%
- 1M
- -4.74%
- YTD
- 9.96%
- 6M
- 7.40%
- 1Y
- 4.94%
- 3Y*
- 29.93%
- 5Y*
- —
- 10Y*
- 9.92%
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Return for Risk
SUNPHARMA.NS vs. NTPC.NS — Risk / Return Rank
SUNPHARMA.NS
NTPC.NS
SUNPHARMA.NS vs. NTPC.NS - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for Sun Pharmaceutical Industries Limited (SUNPHARMA.NS) and NTPC Limited (NTPC.NS). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
| SUNPHARMA.NS | NTPC.NS | Difference | |
|---|---|---|---|
Sharpe ratioReturn per unit of total volatility | -0.01 | 0.26 | -0.28 |
Sortino ratioReturn per unit of downside risk | 0.12 | 0.54 | -0.42 |
Omega ratioGain probability vs. loss probability | 1.02 | 1.06 | -0.05 |
Calmar ratioReturn relative to maximum drawdown | -0.10 | 0.44 | -0.53 |
Martin ratioReturn relative to average drawdown | -0.18 | 0.73 | -0.90 |
Data is calculated on a 1-year rolling basis and updated daily. The trend shows the change in the indicator over the past month. | |||
Loading graphics...
Sharpe Ratios by Period
| SUNPHARMA.NS | NTPC.NS | Difference | |
|---|---|---|---|
Sharpe Ratio (1Y)Calculated over the trailing 1-year period | -0.01 | 0.26 | -0.28 |
Sharpe Ratio (5Y)Calculated over the trailing 5-year period | 1.18 | — | — |
Sharpe Ratio (10Y)Calculated over the trailing 10-year period | 0.32 | 0.12 | +0.19 |
Sharpe Ratio (All Time)Calculated using the full available price history | 0.74 | 0.15 | +0.59 |
Correlation
The correlation between SUNPHARMA.NS and NTPC.NS is 0.22, which is considered to be low. This implies their price changes are not closely related. A low correlation is generally favorable for portfolio diversification, as it helps to reduce overall risk by spreading it across multiple assets with different performance patterns.
Dividends
SUNPHARMA.NS vs. NTPC.NS - Dividend Comparison
SUNPHARMA.NS's dividend yield for the trailing twelve months is around 0.97%, less than NTPC.NS's 2.46% yield.
| TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
SUNPHARMA.NS Sun Pharmaceutical Industries Limited | 0.97% | 0.93% | 0.72% | 0.91% | 1.00% | 0.89% | 0.68% | 0.64% | 0.46% | 0.61% | 0.16% | 0.37% |
NTPC.NS NTPC Limited | 2.46% | 2.61% | 2.70% | 3.05% | 4.21% | 224.72% | 234.68% | 4.61% | 3.44% | 2.70% | 2.03% | 1.71% |
Drawdowns
SUNPHARMA.NS vs. NTPC.NS - Drawdown Comparison
The maximum SUNPHARMA.NS drawdown since its inception was -71.46%, smaller than the maximum NTPC.NS drawdown of -152.78%. Use the drawdown chart below to compare losses from any high point for SUNPHARMA.NS and NTPC.NS.
Loading graphics...
Drawdown Indicators
| SUNPHARMA.NS | NTPC.NS | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -71.46% | -152.78% | +81.32% |
Max Drawdown (1Y)Largest decline over 1 year | -14.83% | -11.00% | -3.83% |
Max Drawdown (5Y)Largest decline over 5 years | -19.13% | -430.91% | +411.78% |
Max Drawdown (10Y)Largest decline over 10 years | -60.80% | -162.32% | +101.52% |
Current DrawdownCurrent decline from peak | -11.71% | -15.54% | +3.83% |
Average DrawdownAverage peak-to-trough decline | -21.03% | -32.93% | +11.90% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 7.98% | 6.64% | +1.34% |
Volatility
SUNPHARMA.NS vs. NTPC.NS - Volatility Comparison
The current volatility for Sun Pharmaceutical Industries Limited (SUNPHARMA.NS) is 6.04%, while NTPC Limited (NTPC.NS) has a volatility of 7.45%. This indicates that SUNPHARMA.NS experiences smaller price fluctuations and is considered to be less risky than NTPC.NS based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading graphics...
Volatility by Period
| SUNPHARMA.NS | NTPC.NS | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 6.04% | 7.45% | -1.41% |
Volatility (6M)Calculated over the trailing 6-month period | 12.58% | 14.43% | -1.85% |
Volatility (1Y)Calculated over the trailing 1-year period | 19.38% | 18.75% | +0.63% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 20.55% | 85.97% | -65.42% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 27.40% | 82.49% | -55.09% |
Financials
SUNPHARMA.NS vs. NTPC.NS - Financials Comparison
This section allows you to compare key financial metrics between Sun Pharmaceutical Industries Limited and NTPC Limited. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.
Total Revenue: Total amount of money received from sales and other business activities